Healthcare: What Was Biogen Thinking?

Industry Focus - Podcast tekijän mukaan The Motley Fool

kokeile Podimo ilmaiseksi 90!!! päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

Kategoriat:

Biogen misses out on a huge deal that Novartis completed with AveXis. Plus, Incyte's phase 3 implosion, and what it means for immuno-oncology more broadly.

Visit the podcast's native language site